Trying to develop a reasonable expectation of days to #FDA approval, given 1) $GERN #imetelstat's #FastTrack status, 2) #ASH18 data, 3) CEO Scarlett's "#derisked" comment, and 4) empirical FDA approval data... https://t.co/KRuaVdILXd
@PeterZeihan Have 2 of your books and find your videos informative, helpful. Please note that delaying your videos by 1 week for release on YouTube is hurting your brand. By the time your video comes out, other people have already shared their analysis - you’re not leading.
The brilliant minds at QIMR Berghofer have just unleashed a potential game-changer in the realm of blood cancer treatment.
Enter imetelstat, a new drug that's proving to be be powerful against #leukaemia cells.
#MichaelSavona presents a captivating talk on the role of Imetelstat in MDSsm @_MDEducation! US focus Meeting. New promising agent, enlightening talk. #innovative!! 🎊🎊@VUMCHemOnc @VUMC_Cancer 👏👏 New Hope for LR-MDS.
Company News: Checking in with Geron after imetelstat's recent ODAC meeting. John Scarlett on the clinical utility, potential commercial dynamics, IP, and more. $GERN
Full video: https://t.co/1ycMeDQ9Dw
$GERN #FDA#AdCom Speaker #4. Cornell professor, researcher, and clinician eloquently made the solid case for #imetelstat — tying together data with actual patient experience.